Research Article
Comparative Clinical Analysis of Gastroenteropancreatic Neuroendocrine Carcinomas with Liver Metastasis and Primary Hepatic Neuroendocrine Carcinomas
Table 5
Univariate analysis of clinical features in primary hepatic neuroendocrine carcinomas.
| Variables | Survival status | | valuesa | Death | Survival |
| Gender | | | 0. 081 | 0.776 | Female | 3 | 2 | | | Male | 6 | 2 | | | Age (years) | | | 2.212 | 0.137 | ≤50 | 5 | 1 | | | >50 | 4 | 3 | | | ALT (U/L) | | | 0.013 | 0.910 | ≤40 | 2 | 3 | | | >40 | 7 | 1 | | | AST (U/L) | | | 0.653 | 0.419 | ≤40 | 1 | 3 | | | >40 | 8 | 1 | | | HB (G/L) | | | 1.090 | 0.296 | ≤110 | 3 | 2 | | | >110 | 6 | 2 | | | Albumin (G/L) | | | 0.141 | 0.707 | ≤35 | 4 | 2 | | | >35 | 5 | 2 | | | ALP (U/L) | | | 0.806 | 0.369 | ≤105 | 3 | 3 | | | >105 | 6 | 1 | | | GGT (U/L) | | | 0.918 | 0.338 | ≤50 | 2 | 2 | | | >50 | 7 | 2 | | | Location | | | 2.518 | 0.113 | Left | 0 | 3 | | | Right | 8 | 1 | | | Unknown | 1 | 0 | | | Number | | | 0.151 | 0.698 | Single | 6 | 4 | | | Multiple | 3 | 0 | | | Diameter | | | 0.044 | 0.835 | ≤5 (cm) | 3 | 0 | | | >5 (cm) | 4 | 4 | | | Unknown | 2 | 0 | | | CA125 (μg/mL) | | | 0.296 | 0.586 | ≤35 | 7 | 4 | | | >35 | 2 | 0 | | | CA19-9 (μg/mL) | | | 0.711 | 0.399 | ≤35 | 7 | 2 | | | >35 | 2 | 2 | | | HbsAg | | | 0.412 | 0.521 | Positive | 1 | 1 | | | Negative | 8 | 3 | | | Treatment | | | 4.585 | 0.032 | Operation | 2 | 2 | | | Others | 7 | 2 | | |
|
|
ALT = alanine aminotransferase, AST = aspartate aminotransferase, HB = hemoglobin, ALP = alkaline phosphatase, GGT = γ-glutamyl transpeptidase, CA125 = carbohydrate antigen 125, CA19-9 = carbohydrate antigen 19-9, HbsAg = hepatitis B virus surface antigen. aKaplan–Meier survival curve and log-rank test. indicates . |